Breast cancer cells with doubled genomes may dodge immunotherapy by turning off key immune signals
An epigenetic mechanism by which tumors manage to hide from the body's immune defenses has just been described by an international scientific team led by the University of Liège and the Dana-Farber Cancer Institute. These ...
May 13, 2026
0
16









